A performance evaluation of a novel human recombinant tissue factor prothrombin time reagent (Revohem™ PT).

about

A performance evaluation of a novel human recombinant tissue factor prothrombin time reagent (Revohem™ PT).

Item

http://www.wikidata.org/entity/Q48028227

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

A performance evaluation of a ...... in time reagent (Revohem™ PT).

@en

A performance evaluation of a ...... actor prothrombin time reagent

@nl

type

Item

label

A performance evaluation of a ...... in time reagent (Revohem™ PT).

@en

A performance evaluation of a ...... actor prothrombin time reagent

@nl

prefLabel

A performance evaluation of a ...... in time reagent (Revohem™ PT).

@en

A performance evaluation of a ...... actor prothrombin time reagent

@nl

P1476

A performance evaluation of a ...... bin time reagent (Revohem™ PT)

@en

P2093

I J Mackie

http://www.w3.org/2001/XMLSchema#string

I Patel

http://www.w3.org/2001/XMLSchema#string

K Kohama

http://www.w3.org/2001/XMLSchema#string

S Dwyer

http://www.w3.org/2001/XMLSchema#string

S J Machin

http://www.w3.org/2001/XMLSchema#string

P2860

The model for end-stage liver disease (MELD)

Effects on routine coagulation screens and assessment of anticoagulant intensity in patients taking oral dabigatran or rivaroxaban: guidance from the British Committee for Standards in Haematology.

Production of human alpha-interferon in silkworm using a baculovirus vector.

Determination of APTT factor sensitivity--the misguiding guideline.

Guidelines on preparation, certification, and use of certified plasmas for ISI calibration and INR determination.

Poor comparability of coagulation screening test with specific measurement in patients receiving direct oral anticoagulants: results from a multicenter/multiplatform study.

Measurement of non-coumarin anticoagulants and their effects on tests of Haemostasis: Guidance from the British Committee for Standards in Haematology.

Comparison of the effect of the anti-Xa direct oral anticoagulants apixaban, edoxaban, and rivaroxaban on coagulation assays.

Influence of dabigatran and rivaroxaban on routine coagulation assays. A nationwide Belgian survey.

Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis.

P304

532-538

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/IJLH.12691

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Chris Gardiner

P J Lane

P577

2017-06-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28603894

http://www.w3.org/2001/XMLSchema#string